Search - tctmd.com

Displaying 101 - 120 of 132

Sort: Relevancy | Date

News Daily News

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Marcus A. Banks

July 12, 2019

News Conference News ACC 2019

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Michael O'Riordan

March 25, 2019

News Daily News

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

L.A. McKeown

March 21, 2019

News Daily News

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

Todd Neale

March 04, 2019

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

Caitlin E. Cox

January 01, 2019

News Features

Top News in Heart Failure: 2018

Shelley Wood

December 28, 2018

News Daily News

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

Shelley Wood

December 10, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2018

Shelley Wood

November 30, 2018

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

News Daily News

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Michael O'Riordan

October 31, 2018

News Daily News

Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’

Todd Neale

September 13, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Daily News

Valsartan Recall Expanded by FDA and European Medicines Agency

Shelley Wood

August 10, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2018

Shelley Wood

August 01, 2018

News Daily News

FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen

Michael O'Riordan

July 16, 2018

News Daily News

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Michael O'Riordan

January 02, 2018

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Daily News

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

Michael O'Riordan

June 05, 2017

Advertisement

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

TCTMD’s Top 10 Most Popular Stories for January 2019

TCTMD’s Top 10 Most Popular Stories for December 2018

Top News in Heart Failure: 2018

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

TCTMD’s Top 10 Most Popular Stories for November 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’

TCTMD’s Top 10 Most Popular Stories for August 2018

Valsartan Recall Expanded by FDA and European Medicines Agency

TCTMD’s Top 10 Most Popular Stories for July 2018

FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Generic ARBs Linked to Increased Adverse Events

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content